MEDANTAHospital
Global Health Ltd — Profit & Loss Statement
₹961.10
-3.43%
Global Health Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Pretax Income | 647.26 Cr | 627.10 Cr | 449.29 Cr | 280.56 Cr | — |
| Tax Effect Of Unusual Items | -12.79 Cr | 0.00 | -2.28 Cr | -1.00 Cr | — |
| Tax Rate For Calcs | 0.26 | 0.24 | 0.27 | 0.30 | — |
| Normalized EBITDA | 956.16 Cr | 873.74 Cr | 684.97 Cr | 493.09 Cr | — |
| Total Unusual Items | -49.90 Cr | 0.00 | -8.30 Cr | -3.34 Cr | — |
| Total Unusual Items Excluding Goodwill | -49.90 Cr | 0.00 | -8.30 Cr | -3.34 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 481.44 Cr | 478.19 Cr | 326.08 Cr | 196.20 Cr | — |
| Reconciled Depreciation | 193.75 Cr | 172.73 Cr | 149.91 Cr | 129.71 Cr | — |
| Reconciled Cost Of Revenue | 879.67 Cr | 759.36 Cr | 625.28 Cr | 542.93 Cr | — |
| EBITDA | 906.26 Cr | 873.74 Cr | 676.67 Cr | 489.76 Cr | — |
| EBIT | 712.52 Cr | 701.01 Cr | 526.75 Cr | 360.04 Cr | — |
| Net Interest Income | -65.26 Cr | -73.91 Cr | -50.79 Cr | -79.49 Cr | — |
| Interest Expense | 65.26 Cr | 73.91 Cr | 77.46 Cr | 79.49 Cr | — |
| Normalized Income | 518.54 Cr | 478.19 Cr | 332.10 Cr | 198.53 Cr | — |
| Net Income From Continuing And Discontinued Operation | 481.44 Cr | 478.19 Cr | 326.08 Cr | 196.20 Cr | — |
| Total Expenses | 3.01K Cr | 2.65K Cr | 2.18K Cr | 1.84K Cr | — |
| Diluted Average Shares | 26.87 Cr | 26.86 Cr | 25.95 Cr | 25.37 Cr | — |
| Basic Average Shares | 26.87 Cr | 26.86 Cr | 25.92 Cr | 25.32 Cr | — |
| Diluted EPS | 17.92 | 17.80 | 12.57 | 7.73 | — |
| Basic EPS | 17.92 | 17.80 | 12.58 | 7.75 | — |
| Diluted NI Availto Com Stockholders | 481.44 Cr | 478.19 Cr | 326.08 Cr | 196.20 Cr | — |
| Net Income Common Stockholders | 481.44 Cr | 478.19 Cr | 326.08 Cr | 196.20 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 481.44 Cr | 478.19 Cr | 326.08 Cr | 196.20 Cr | — |
| Minority Interests | 0.12 Cr | 0.13 Cr | 0.00 | 0.00 | — |
| Net Income Including Noncontrolling Interests | 481.32 Cr | 478.06 Cr | 326.08 Cr | 196.20 Cr | — |
| Net Income Continuous Operations | 481.32 Cr | 478.06 Cr | 326.08 Cr | 196.20 Cr | — |
| Tax Provision | 165.94 Cr | 149.04 Cr | 123.21 Cr | 84.36 Cr | — |
| Other Non Operating Income Expenses | 79.10 Cr | 74.66 Cr | 13.75 Cr | 38.52 Cr | — |
| Special Income Charges | -49.90 Cr | 0.00 | -8.30 Cr | -3.34 Cr | — |
| Net Non Operating Interest Income Expense | -65.26 Cr | -73.91 Cr | -50.79 Cr | -79.49 Cr | — |
| Interest Expense Non Operating | 65.26 Cr | 73.91 Cr | 77.46 Cr | 79.49 Cr | — |
| Operating Income | 683.32 Cr | 626.35 Cr | 499.06 Cr | 324.86 Cr | — |
| Operating Expense | 2.13K Cr | 1.89K Cr | 1.56K Cr | 1.30K Cr | — |
| Other Operating Expenses | 613.70 Cr | 554.79 Cr | 313.27 Cr | 366.74 Cr | — |
| Depreciation And Amortization In Income Statement | 193.75 Cr | 172.73 Cr | 149.91 Cr | 129.71 Cr | — |
| Depreciation Income Statement | 193.75 Cr | 172.73 Cr | 147.41 Cr | 129.71 Cr | — |
| Selling General And Administration | 497.34 Cr | 427.03 Cr | 421.13 Cr | 235.10 Cr | — |
| General And Administrative Expense | 497.34 Cr | 427.03 Cr | 396.22 Cr | 235.10 Cr | — |
| Gross Profit | 2.81K Cr | 2.52K Cr | 2.06K Cr | 1.62K Cr | — |
| Cost Of Revenue | 879.67 Cr | 759.36 Cr | 625.28 Cr | 542.93 Cr | — |
| Total Revenue | 3.69K Cr | 3.28K Cr | 2.68K Cr | 2.17K Cr | — |
| Operating Revenue | 3.69K Cr | 3.28K Cr | 2.68K Cr | 2.17K Cr | — |
| Interest Income | — | 59.68 Cr | 35.54 Cr | 16.72 Cr | 17.76 Cr |
| Rent Expense Supplemental | — | 62.10 Cr | 63.37 Cr | 53.76 Cr | 36.49 Cr |
| Other Special Charges | — | -0.82 Cr | 0.68 Cr | -2.63 Cr | -3.00 Cr |
| Write Off | — | 29.31 Cr | 7.62 Cr | 3.34 Cr | 14.26 Cr |
| Total Other Finance Cost | — | 11.24 Cr | 8.87 Cr | 7.37 Cr | 5.54 Cr |
| Interest Income Non Operating | — | 59.68 Cr | 35.54 Cr | 16.72 Cr | 17.76 Cr |
| Amortization | — | 2.50 Cr | 2.50 Cr | 2.26 Cr | 2.09 Cr |
| Research And Development | — | 0.04 Cr | 0.03 Cr | 0.06 Cr | 0.03 Cr |
| Selling And Marketing Expense | — | 29.18 Cr | 24.91 Cr | 3.12 Cr | 2.39 Cr |
| Rent And Landing Fees | — | 62.10 Cr | 63.37 Cr | 53.76 Cr | 36.49 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Global Health Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.